Clinical Trials in Houston

Showing 2081-2100 of 8,625 trials

Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

NCT04075591

This study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 sites. A total of 383 subjects will be enrolled to achieve approximately 268 treated subjects, resulting in at least 241 evaluable subjects at the point of refractive stability. After signing the informed consent, subjects meeting all inclusion and exclusion criteria in both eyes may be scheduled for surgery. The follow-up visit schedule will be the same for each operative eye.

Refractive Error

AMO Development, LLC219 participantsStarted Sep 2019

Los Angeles, California, United States • Chicago, Illinois, United States • Las Vegas, Nevada, United States +7 more locations

COMPLETEDPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

NCT03823287

This study will evaluate the efficacy, safety, durability, and pharmacokinetics of faricimab administered at intervals as specified in the protocol, compared with aflibercept once every 8 weeks (Q8W), in participants with neovascular age-related macular degeneration (nAMD).

Wet Macular Degeneration

Hoffmann-La Roche671 participantsStarted Feb 2019

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +158 more locations

Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Find Trials by Condition in Houston

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

Evaluation of the Impact of Stress on IVF Outcome

Locating Biomarkers in OCD Through Behavioral Tasks

SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

EXOMIND (BTL-699-2) for Improvement of Mental Well-being